mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.1 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.1 |